Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapies
Tamoxifen Not Harmful to Endothelial Function
May 6th, 2000
Scientists say that despite tamoxifen's estrogen agonist and antagonist characteristics, the drug is not harmful to endothelial function in postmenopausal breast cancer patients. To assess the potentially negative effect of tamoxifen on the cardiovascular system, Paul J.L. Ong and colleagues designed a study of 22 postmenopausal women with breast cancer. The women fell into one of three groups: Group 1: Recently diagnosed breast cancer patients Group 2: Patients who had been receiving long-term tamoxifen Group 3: Breast cancer patients in remission who did not take tamoxifen Ong et al. assessed Group 1 both...
Source: Women's Health Weekly (2000-05-06)
|
